Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
Authors list
HA Azim S Michiels F Zagouri S Delaloge M Filipits M Namer P Neven WF Symmans A Thompson F André S Loi Charles SwantonAbstract
We critically evaluated the available evidence on genomic tests in breast cancer to define their prognostic ability and likelihood to determine treatment benefit.
Full text links
Publisher website (DOI) 10.1093/annonc/mds645
Europe PubMed Central 23337633
Pubmed 23337633
Keywords
Type of publication